These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

636 related items for PubMed ID: 16393297

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The effects of withdrawing tegaserod treatment in comparison with continuous treatment in irritable bowel syndrome patients with abdominal pain/discomfort, bloating and constipation: a clinical study.
    Bardhan KD, Forbes A, Marsden CL, Mason T, Short G.
    Aliment Pharmacol Ther; 2004 Jul 15; 20(2):213-22. PubMed ID: 15233702
    [Abstract] [Full Text] [Related]

  • 5. Effect of tegaserod on work and daily activity in irritable bowel syndrome with constipation.
    Reilly MC, Barghout V, McBurney CR, Niecko TE.
    Aliment Pharmacol Ther; 2005 Sep 01; 22(5):373-80. PubMed ID: 16128674
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A randomized, multicenter comparison of polyethylene glycol laxative and tegaserod in treatment of patients with chronic constipation.
    Di Palma JA, Cleveland MV, McGowan J, Herrera JL.
    Am J Gastroenterol; 2007 Sep 01; 102(9):1964-71. PubMed ID: 17573794
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Tegaserod: long-term treatment for irritable bowel syndrome patients with constipation in primary care.
    Layer P, Keller J, Mueller-Lissner S, Rüegg P, Loeffler H.
    Digestion; 2005 Sep 01; 71(4):238-44. PubMed ID: 16024929
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Tegaserod for female patients suffering from IBS with mixed bowel habits or constipation: a randomized controlled trial.
    Chey WD, Paré P, Viegas A, Ligozio G, Shetzline MA.
    Am J Gastroenterol; 2008 May 01; 103(5):1217-25. PubMed ID: 18477346
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Open-label, dose-ranging pilot study of 4 weeks of low-dose therapy with sodium phosphate tablets in chronically constipated adults.
    Medoff J, Katz S, Malik P, Pambianco D, Pruitt R, Poulos J, Rank J, Rose M.
    Clin Ther; 2004 Sep 01; 26(9):1479-91. PubMed ID: 15531010
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Tegaserod for the treatment of irritable bowel syndrome and chronic constipation.
    Evans BW, Clark WK, Moore DJ, Whorwell PJ.
    Cochrane Database Syst Rev; 2007 Oct 17; (4):CD003960. PubMed ID: 17943807
    [Abstract] [Full Text] [Related]

  • 19. Effect of tegaserod on recto-sigmoid tonic and phasic activity in constipation-predominant irritable bowel syndrome.
    Di Stefano M, Miceli E, Mazzocchi S, Tana P, Missanelli A, Corazza GR.
    Am J Gastroenterol; 2007 Aug 17; 102(8):1720-6. PubMed ID: 17521397
    [Abstract] [Full Text] [Related]

  • 20. Characteristics, diagnostic and symptom profile of patients receiving tegaserod in routine clinical practice in Canada.
    Bradette M, Wawer AR, Balshaw R, Kelly S, Barbeau M, Sambrook R.
    Can J Clin Pharmacol; 2007 Aug 17; 14(3):e291-300. PubMed ID: 18025544
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.